Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Practice Guidelines as Topic | 47 | 2022 | 1039 | 11.130 |
Why?
|
Physician-Patient Relations | 9 | 2023 | 625 | 3.410 |
Why?
|
Evidence-Based Medicine | 14 | 2019 | 430 | 3.060 |
Why?
|
Physicians | 8 | 2023 | 689 | 2.930 |
Why?
|
Anticoagulants | 10 | 2022 | 425 | 1.890 |
Why?
|
Humans | 124 | 2024 | 88835 | 1.790 |
Why?
|
Mass Screening | 8 | 2022 | 631 | 1.560 |
Why?
|
Primary Prevention | 4 | 2019 | 81 | 1.470 |
Why?
|
Cardiology | 5 | 2021 | 114 | 1.450 |
Why?
|
Pulmonary Embolism | 4 | 2021 | 228 | 1.440 |
Why?
|
Coronary Disease | 3 | 2019 | 260 | 1.400 |
Why?
|
Vena Cava Filters | 4 | 2021 | 97 | 1.390 |
Why?
|
Students, Medical | 5 | 2023 | 418 | 1.390 |
Why?
|
Biomedical Research | 4 | 2018 | 397 | 1.210 |
Why?
|
Helicobacter Infections | 2 | 2018 | 37 | 1.180 |
Why?
|
Helicobacter pylori | 2 | 2018 | 37 | 1.180 |
Why?
|
Guidelines as Topic | 3 | 2021 | 160 | 1.150 |
Why?
|
Venous Thromboembolism | 6 | 2022 | 159 | 1.150 |
Why?
|
Cardiovascular Diseases | 4 | 2021 | 704 | 1.130 |
Why?
|
Randomized Controlled Trials as Topic | 8 | 2021 | 832 | 1.110 |
Why?
|
Thrombolytic Therapy | 2 | 2020 | 232 | 1.060 |
Why?
|
Chest Pain | 3 | 2022 | 42 | 1.060 |
Why?
|
Societies, Medical | 7 | 2021 | 566 | 1.050 |
Why?
|
Anti-Bacterial Agents | 6 | 2024 | 782 | 1.040 |
Why?
|
Lyme Disease | 2 | 2022 | 9 | 1.030 |
Why?
|
Osteoporosis | 3 | 2018 | 122 | 1.020 |
Why?
|
Atrial Fibrillation | 4 | 2021 | 349 | 0.990 |
Why?
|
Myocardial Infarction | 3 | 2013 | 372 | 0.990 |
Why?
|
Clinical Clerkship | 4 | 2015 | 118 | 0.990 |
Why?
|
Colonoscopy | 5 | 2020 | 279 | 0.980 |
Why?
|
Attitude of Health Personnel | 2 | 2019 | 643 | 0.930 |
Why?
|
Early Detection of Cancer | 3 | 2017 | 411 | 0.910 |
Why?
|
Professional Practice | 2 | 2013 | 46 | 0.890 |
Why?
|
Early Diagnosis | 2 | 2014 | 125 | 0.890 |
Why?
|
Clostridium Infections | 3 | 2022 | 124 | 0.880 |
Why?
|
Renal Insufficiency, Chronic | 3 | 2015 | 219 | 0.840 |
Why?
|
Anxiety Disorders | 2 | 2022 | 151 | 0.830 |
Why?
|
Borrelia burgdorferi | 1 | 2022 | 6 | 0.820 |
Why?
|
Exercise Test | 2 | 2013 | 165 | 0.810 |
Why?
|
American Heart Association | 4 | 2022 | 93 | 0.810 |
Why?
|
Spider Bites | 1 | 2021 | 2 | 0.810 |
Why?
|
Antithrombins | 3 | 2020 | 16 | 0.800 |
Why?
|
Antibodies, Bacterial | 1 | 2022 | 99 | 0.790 |
Why?
|
Physical Examination | 2 | 2019 | 148 | 0.780 |
Why?
|
Research Design | 4 | 2019 | 597 | 0.770 |
Why?
|
Disabled Persons | 1 | 2022 | 73 | 0.770 |
Why?
|
Vitamin K | 2 | 2018 | 25 | 0.770 |
Why?
|
Gastroplasty | 1 | 2021 | 25 | 0.770 |
Why?
|
Fingers | 1 | 2021 | 69 | 0.760 |
Why?
|
Classification | 1 | 2021 | 54 | 0.760 |
Why?
|
Selection Bias | 1 | 2020 | 37 | 0.750 |
Why?
|
Practice Patterns, Physicians' | 3 | 2019 | 598 | 0.740 |
Why?
|
School Admission Criteria | 1 | 2020 | 23 | 0.740 |
Why?
|
Risk Assessment | 6 | 2020 | 2285 | 0.730 |
Why?
|
Death | 1 | 2021 | 85 | 0.730 |
Why?
|
Endoscopy, Gastrointestinal | 2 | 2018 | 156 | 0.710 |
Why?
|
Blood Transfusion | 2 | 2022 | 166 | 0.710 |
Why?
|
Guilt | 1 | 2019 | 11 | 0.700 |
Why?
|
Hematuria | 2 | 2021 | 50 | 0.700 |
Why?
|
Terminology as Topic | 1 | 2021 | 221 | 0.700 |
Why?
|
Emergency Service, Hospital | 4 | 2022 | 518 | 0.700 |
Why?
|
Attitude to Death | 1 | 2019 | 36 | 0.690 |
Why?
|
Factor Xa Inhibitors | 2 | 2019 | 23 | 0.690 |
Why?
|
Physicians, Primary Care | 1 | 2021 | 105 | 0.690 |
Why?
|
Decision Making | 2 | 2018 | 664 | 0.680 |
Why?
|
Inpatients | 1 | 2022 | 310 | 0.660 |
Why?
|
Memory | 1 | 2021 | 220 | 0.660 |
Why?
|
Atrial Appendage | 1 | 2019 | 30 | 0.650 |
Why?
|
Obesity, Morbid | 1 | 2021 | 233 | 0.630 |
Why?
|
Psychotherapy | 1 | 2019 | 73 | 0.630 |
Why?
|
Adrenal Cortex Hormones | 2 | 2019 | 265 | 0.630 |
Why?
|
Blood Coagulation Factors | 1 | 2018 | 20 | 0.630 |
Why?
|
Dyspepsia | 1 | 2018 | 9 | 0.630 |
Why?
|
Interprofessional Relations | 1 | 2019 | 122 | 0.620 |
Why?
|
Patient Harm | 1 | 2018 | 7 | 0.620 |
Why?
|
Perioperative Care | 2 | 2022 | 168 | 0.620 |
Why?
|
Trust | 1 | 2019 | 98 | 0.610 |
Why?
|
Diarrhea | 1 | 2019 | 182 | 0.610 |
Why?
|
Peanut Hypersensitivity | 1 | 2018 | 15 | 0.610 |
Why?
|
Diabetic Foot | 1 | 2017 | 14 | 0.610 |
Why?
|
Secondary Prevention | 4 | 2021 | 158 | 0.600 |
Why?
|
Bone Density Conservation Agents | 1 | 2018 | 46 | 0.600 |
Why?
|
Psychomotor Agitation | 1 | 2017 | 26 | 0.600 |
Why?
|
Diverticulitis, Colonic | 1 | 2017 | 11 | 0.590 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2017 | 25 | 0.590 |
Why?
|
Adult | 26 | 2022 | 26437 | 0.580 |
Why?
|
Fractures, Bone | 2 | 2018 | 126 | 0.580 |
Why?
|
Polysomnography | 1 | 2017 | 150 | 0.580 |
Why?
|
Low Back Pain | 1 | 2017 | 41 | 0.580 |
Why?
|
Social Media | 1 | 2019 | 91 | 0.580 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2019 | 113 | 0.570 |
Why?
|
Counseling | 2 | 2015 | 163 | 0.570 |
Why?
|
Diagnostic Tests, Routine | 1 | 2017 | 64 | 0.570 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2017 | 52 | 0.550 |
Why?
|
Catheter Ablation | 1 | 2019 | 252 | 0.550 |
Why?
|
Postthrombotic Syndrome | 1 | 2016 | 3 | 0.550 |
Why?
|
Antipsychotic Agents | 1 | 2017 | 128 | 0.550 |
Why?
|
Internship and Residency | 3 | 2021 | 1040 | 0.550 |
Why?
|
Diagnostic Errors | 1 | 2017 | 160 | 0.550 |
Why?
|
Glucose Metabolism Disorders | 1 | 2016 | 3 | 0.540 |
Why?
|
Opiate Substitution Treatment | 1 | 2016 | 39 | 0.540 |
Why?
|
Hemorrhage | 1 | 2018 | 278 | 0.540 |
Why?
|
Elective Surgical Procedures | 1 | 2017 | 126 | 0.540 |
Why?
|
Wearable Electronic Devices | 1 | 2016 | 25 | 0.540 |
Why?
|
Smartphone | 1 | 2016 | 39 | 0.540 |
Why?
|
Referral and Consultation | 2 | 2021 | 341 | 0.530 |
Why?
|
Calcineurin Inhibitors | 1 | 2016 | 53 | 0.530 |
Why?
|
Education, Medical, Undergraduate | 1 | 2018 | 178 | 0.530 |
Why?
|
Dissent and Disputes | 1 | 2015 | 29 | 0.530 |
Why?
|
Erythrocytes | 1 | 2016 | 254 | 0.520 |
Why?
|
Psychotic Disorders | 1 | 2017 | 192 | 0.520 |
Why?
|
Hypnotics and Sedatives | 1 | 2017 | 131 | 0.520 |
Why?
|
Language | 1 | 2017 | 154 | 0.520 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2018 | 237 | 0.520 |
Why?
|
Dementia | 1 | 2017 | 190 | 0.520 |
Why?
|
Antihypertensive Agents | 1 | 2017 | 249 | 0.520 |
Why?
|
Dermatitis, Atopic | 1 | 2016 | 55 | 0.520 |
Why?
|
Educational Measurement | 2 | 2020 | 231 | 0.510 |
Why?
|
Venous Thrombosis | 2 | 2021 | 250 | 0.510 |
Why?
|
Peripheral Arterial Disease | 1 | 2016 | 94 | 0.510 |
Why?
|
Pneumococcal Vaccines | 1 | 2015 | 28 | 0.500 |
Why?
|
Consensus | 1 | 2017 | 355 | 0.500 |
Why?
|
Preoperative Care | 1 | 2017 | 395 | 0.500 |
Why?
|
Population Surveillance | 1 | 2016 | 216 | 0.490 |
Why?
|
Hodgkin Disease | 1 | 2016 | 181 | 0.490 |
Why?
|
Streptococcus pneumoniae | 1 | 2015 | 49 | 0.490 |
Why?
|
Feedback, Psychological | 1 | 2015 | 19 | 0.490 |
Why?
|
Pneumococcal Infections | 1 | 2015 | 47 | 0.490 |
Why?
|
Urologic Neoplasms | 1 | 2015 | 81 | 0.490 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2015 | 104 | 0.490 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2017 | 216 | 0.490 |
Why?
|
Papillomavirus Infections | 2 | 2014 | 261 | 0.490 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2016 | 154 | 0.480 |
Why?
|
Overweight | 1 | 2015 | 119 | 0.480 |
Why?
|
Television | 1 | 2014 | 29 | 0.470 |
Why?
|
Famous Persons | 1 | 2014 | 8 | 0.470 |
Why?
|
Papillomavirus Vaccines | 1 | 2014 | 58 | 0.460 |
Why?
|
Acute Disease | 4 | 2021 | 837 | 0.460 |
Why?
|
Health Behavior | 1 | 2015 | 184 | 0.460 |
Why?
|
Stroke | 4 | 2021 | 978 | 0.460 |
Why?
|
Vaccination | 2 | 2014 | 273 | 0.460 |
Why?
|
Opioid-Related Disorders | 1 | 2016 | 183 | 0.440 |
Why?
|
United States | 13 | 2024 | 6928 | 0.440 |
Why?
|
Empirical Research | 1 | 2013 | 19 | 0.440 |
Why?
|
Epidemiologic Research Design | 1 | 2013 | 22 | 0.440 |
Why?
|
Authorship | 1 | 2013 | 23 | 0.430 |
Why?
|
Faculty, Medical | 1 | 2015 | 185 | 0.420 |
Why?
|
Administration, Oral | 3 | 2020 | 682 | 0.420 |
Why?
|
Antibiotic Prophylaxis | 2 | 2024 | 77 | 0.420 |
Why?
|
Crohn Disease | 1 | 2019 | 756 | 0.410 |
Why?
|
Diet | 1 | 2015 | 442 | 0.410 |
Why?
|
Exercise | 1 | 2015 | 322 | 0.410 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2022 | 1174 | 0.410 |
Why?
|
Attitude | 1 | 2013 | 130 | 0.410 |
Why?
|
Diagnostic Imaging | 1 | 2016 | 478 | 0.400 |
Why?
|
Hypertension | 1 | 2017 | 741 | 0.400 |
Why?
|
Biomedical Technology | 1 | 2011 | 21 | 0.400 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2014 | 294 | 0.390 |
Why?
|
Myocardial Revascularization | 1 | 2011 | 29 | 0.390 |
Why?
|
Surgical Wound Infection | 2 | 2024 | 201 | 0.390 |
Why?
|
Electrocardiography | 4 | 2022 | 493 | 0.380 |
Why?
|
Coronary Stenosis | 1 | 2011 | 39 | 0.380 |
Why?
|
Primary Health Care | 1 | 2014 | 350 | 0.370 |
Why?
|
Female | 17 | 2022 | 45893 | 0.360 |
Why?
|
Colorectal Neoplasms | 1 | 2017 | 980 | 0.340 |
Why?
|
Clinical Trials as Topic | 2 | 2012 | 1146 | 0.340 |
Why?
|
Guideline Adherence | 1 | 2011 | 228 | 0.340 |
Why?
|
Neoplasms | 2 | 2021 | 3020 | 0.330 |
Why?
|
Diagnosis, Differential | 4 | 2022 | 1590 | 0.330 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2021 | 699 | 0.310 |
Why?
|
Warfarin | 2 | 2019 | 104 | 0.310 |
Why?
|
Standard of Care | 3 | 2013 | 65 | 0.300 |
Why?
|
Male | 14 | 2021 | 42127 | 0.300 |
Why?
|
Adaptation, Psychological | 2 | 2019 | 166 | 0.300 |
Why?
|
Heart Failure | 3 | 2022 | 1172 | 0.290 |
Why?
|
Curriculum | 1 | 2012 | 567 | 0.290 |
Why?
|
Tomography, X-Ray Computed | 2 | 2014 | 2647 | 0.280 |
Why?
|
Registries | 1 | 2011 | 770 | 0.280 |
Why?
|
Acne Vulgaris | 2 | 2017 | 35 | 0.280 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 2 | 2021 | 256 | 0.270 |
Why?
|
Postoperative Complications | 2 | 2021 | 2273 | 0.270 |
Why?
|
Middle Aged | 8 | 2021 | 25783 | 0.260 |
Why?
|
Advisory Committees | 2 | 2015 | 88 | 0.240 |
Why?
|
Periodicals as Topic | 2 | 2019 | 168 | 0.240 |
Why?
|
Antimicrobial Stewardship | 1 | 2024 | 23 | 0.240 |
Why?
|
Aged | 7 | 2022 | 19014 | 0.240 |
Why?
|
Quality Improvement | 2 | 2020 | 446 | 0.230 |
Why?
|
Risk Factors | 3 | 2022 | 5447 | 0.230 |
Why?
|
Faculty | 1 | 2023 | 33 | 0.220 |
Why?
|
Professionalism | 1 | 2023 | 25 | 0.210 |
Why?
|
Treatment Outcome | 4 | 2021 | 8177 | 0.210 |
Why?
|
Leukocyte L1 Antigen Complex | 2 | 2020 | 45 | 0.210 |
Why?
|
Weight Reduction Programs | 1 | 2022 | 13 | 0.210 |
Why?
|
Tick Bites | 1 | 2022 | 1 | 0.210 |
Why?
|
Child | 4 | 2022 | 7112 | 0.200 |
Why?
|
Asymptomatic Diseases | 1 | 2022 | 45 | 0.200 |
Why?
|
Lung Neoplasms | 1 | 2014 | 2344 | 0.200 |
Why?
|
Frail Elderly | 1 | 2022 | 81 | 0.200 |
Why?
|
Spiders | 1 | 2021 | 16 | 0.200 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2021 | 59 | 0.190 |
Why?
|
Weight Loss | 2 | 2022 | 225 | 0.190 |
Why?
|
Thoracic Surgical Procedures | 1 | 2022 | 55 | 0.190 |
Why?
|
Necrosis | 1 | 2021 | 209 | 0.190 |
Why?
|
Immunologic Factors | 2 | 2020 | 170 | 0.190 |
Why?
|
Career Choice | 2 | 2021 | 148 | 0.190 |
Why?
|
Internal Medicine | 3 | 2015 | 355 | 0.190 |
Why?
|
Empathy | 1 | 2023 | 150 | 0.190 |
Why?
|
Feces | 2 | 2020 | 327 | 0.190 |
Why?
|
Foramen Ovale, Patent | 1 | 2021 | 18 | 0.190 |
Why?
|
Acute Coronary Syndrome | 1 | 2021 | 30 | 0.190 |
Why?
|
Embolectomy | 1 | 2020 | 6 | 0.190 |
Why?
|
Drug Therapy, Combination | 2 | 2021 | 780 | 0.190 |
Why?
|
Home Care Services | 1 | 2021 | 73 | 0.180 |
Why?
|
History, 21st Century | 1 | 2021 | 180 | 0.180 |
Why?
|
Recurrence | 2 | 2020 | 1140 | 0.180 |
Why?
|
Cause of Death | 1 | 2021 | 266 | 0.180 |
Why?
|
History, 20th Century | 1 | 2021 | 310 | 0.180 |
Why?
|
Pulmonary Medicine | 1 | 2020 | 46 | 0.180 |
Why?
|
Time Factors | 2 | 2019 | 5311 | 0.180 |
Why?
|
Europe | 1 | 2020 | 319 | 0.170 |
Why?
|
Anxiety | 1 | 2022 | 307 | 0.170 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2021 | 143 | 0.170 |
Why?
|
Colonic Polyps | 1 | 2020 | 132 | 0.170 |
Why?
|
Irritable Bowel Syndrome | 2 | 2020 | 46 | 0.170 |
Why?
|
Schools, Medical | 1 | 2020 | 134 | 0.170 |
Why?
|
Communication | 1 | 2023 | 457 | 0.170 |
Why?
|
Hepatitis C | 1 | 2021 | 170 | 0.170 |
Why?
|
Illinois | 1 | 2020 | 472 | 0.170 |
Why?
|
Salvage Therapy | 1 | 2020 | 235 | 0.170 |
Why?
|
Death, Sudden, Cardiac | 1 | 2019 | 51 | 0.170 |
Why?
|
Mitral Valve | 1 | 2021 | 261 | 0.170 |
Why?
|
Mitral Valve Insufficiency | 1 | 2021 | 192 | 0.170 |
Why?
|
Endovascular Procedures | 1 | 2023 | 268 | 0.160 |
Why?
|
United States Department of Veterans Affairs | 1 | 2019 | 31 | 0.160 |
Why?
|
Lower Gastrointestinal Tract | 1 | 2018 | 8 | 0.160 |
Why?
|
Transcatheter Aortic Valve Replacement | 1 | 2019 | 51 | 0.160 |
Why?
|
Drug-Related Side Effects and Adverse Reactions | 1 | 2021 | 201 | 0.160 |
Why?
|
Thyroid Diseases | 1 | 2019 | 105 | 0.160 |
Why?
|
Adenoma | 1 | 2020 | 246 | 0.160 |
Why?
|
Influenza, Human | 2 | 2000 | 336 | 0.160 |
Why?
|
Remission Induction | 2 | 2020 | 738 | 0.160 |
Why?
|
Egg Hypersensitivity | 1 | 2018 | 4 | 0.160 |
Why?
|
Blood Coagulation Tests | 1 | 2018 | 35 | 0.160 |
Why?
|
Eczema | 1 | 2018 | 7 | 0.160 |
Why?
|
Administration, Intravenous | 1 | 2018 | 57 | 0.160 |
Why?
|
Antidepressive Agents | 1 | 2019 | 111 | 0.160 |
Why?
|
Lung Diseases, Interstitial | 1 | 2021 | 253 | 0.150 |
Why?
|
Syncope | 1 | 2018 | 34 | 0.150 |
Why?
|
Vancomycin | 1 | 2018 | 73 | 0.150 |
Why?
|
Education, Medical, Continuing | 1 | 2019 | 105 | 0.150 |
Why?
|
Fecal Microbiota Transplantation | 1 | 2018 | 64 | 0.150 |
Why?
|
Osteoporosis, Postmenopausal | 1 | 2018 | 33 | 0.150 |
Why?
|
Proton Pump Inhibitors | 1 | 2018 | 34 | 0.150 |
Why?
|
Endoscopy | 1 | 2021 | 344 | 0.150 |
Why?
|
Arrhythmias, Cardiac | 1 | 2019 | 197 | 0.150 |
Why?
|
Defibrillators, Implantable | 1 | 2019 | 142 | 0.150 |
Why?
|
Thyroxine | 1 | 2019 | 347 | 0.150 |
Why?
|
Rivaroxaban | 1 | 2017 | 12 | 0.150 |
Why?
|
Mentors | 1 | 2018 | 85 | 0.150 |
Why?
|
Review Literature as Topic | 1 | 2017 | 21 | 0.150 |
Why?
|
Research Report | 2 | 2019 | 44 | 0.150 |
Why?
|
Aortic Valve Stenosis | 1 | 2019 | 143 | 0.150 |
Why?
|
Dabigatran | 1 | 2017 | 25 | 0.150 |
Why?
|
Medical Order Entry Systems | 1 | 2017 | 25 | 0.150 |
Why?
|
Intestinal Obstruction | 1 | 2017 | 88 | 0.140 |
Why?
|
Continuity of Patient Care | 1 | 2019 | 172 | 0.140 |
Why?
|
Aortic Valve | 1 | 2019 | 243 | 0.140 |
Why?
|
Pyridones | 1 | 2017 | 53 | 0.140 |
Why?
|
Meta-Analysis as Topic | 1 | 2017 | 86 | 0.140 |
Why?
|
Physical Therapy Modalities | 1 | 2017 | 83 | 0.140 |
Why?
|
Bone Density | 1 | 2018 | 209 | 0.140 |
Why?
|
Personal Satisfaction | 1 | 2017 | 63 | 0.140 |
Why?
|
Coronary Angiography | 2 | 2021 | 239 | 0.140 |
Why?
|
Thiazoles | 1 | 2017 | 128 | 0.140 |
Why?
|
Analgesics | 1 | 2017 | 119 | 0.140 |
Why?
|
Decision Support Systems, Clinical | 1 | 2017 | 105 | 0.140 |
Why?
|
Device Approval | 2 | 2013 | 13 | 0.140 |
Why?
|
Point-of-Care Systems | 1 | 2017 | 148 | 0.140 |
Why?
|
Pyrazoles | 1 | 2017 | 150 | 0.130 |
Why?
|
Pregnancy Complications | 1 | 2019 | 345 | 0.130 |
Why?
|
Erythrocyte Transfusion | 1 | 2016 | 72 | 0.130 |
Why?
|
Evidence-Based Practice | 1 | 2016 | 47 | 0.130 |
Why?
|
Contraindications | 2 | 2015 | 70 | 0.130 |
Why?
|
Biomarkers | 2 | 2020 | 1751 | 0.130 |
Why?
|
Tinnitus | 1 | 2016 | 21 | 0.130 |
Why?
|
Drug Prescriptions | 1 | 2017 | 144 | 0.130 |
Why?
|
Disease Progression | 1 | 2020 | 1482 | 0.130 |
Why?
|
Arterial Occlusive Diseases | 1 | 2016 | 109 | 0.130 |
Why?
|
Obesity | 1 | 2022 | 964 | 0.130 |
Why?
|
Unnecessary Procedures | 1 | 2015 | 51 | 0.130 |
Why?
|
Physician's Role | 1 | 2017 | 177 | 0.130 |
Why?
|
Pregnancy | 3 | 2022 | 3002 | 0.130 |
Why?
|
Immunotherapy | 1 | 2021 | 664 | 0.130 |
Why?
|
Immunization, Secondary | 1 | 2015 | 32 | 0.130 |
Why?
|
Pyridines | 1 | 2017 | 315 | 0.120 |
Why?
|
Asthma | 2 | 2022 | 975 | 0.120 |
Why?
|
Combined Modality Therapy | 1 | 2019 | 1708 | 0.120 |
Why?
|
Antibodies, Monoclonal, Humanized | 1 | 2020 | 967 | 0.120 |
Why?
|
Learning | 1 | 2018 | 283 | 0.120 |
Why?
|
Vaginal Smears | 1 | 2014 | 70 | 0.120 |
Why?
|
Life Expectancy | 1 | 2014 | 89 | 0.120 |
Why?
|
Delivery of Health Care | 1 | 2019 | 433 | 0.120 |
Why?
|
Laparoscopy | 1 | 2021 | 771 | 0.120 |
Why?
|
Gastrointestinal Agents | 1 | 2015 | 171 | 0.110 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2015 | 93 | 0.110 |
Why?
|
Blood Pressure | 1 | 2017 | 898 | 0.110 |
Why?
|
Colitis, Ulcerative | 1 | 2020 | 733 | 0.110 |
Why?
|
Journal Impact Factor | 1 | 2013 | 15 | 0.110 |
Why?
|
Chronic Disease | 1 | 2017 | 947 | 0.110 |
Why?
|
Peer Review, Research | 1 | 2013 | 36 | 0.110 |
Why?
|
Pharmacogenetics | 1 | 2017 | 443 | 0.110 |
Why?
|
Comorbidity | 1 | 2017 | 947 | 0.110 |
Why?
|
Observation | 1 | 2013 | 38 | 0.110 |
Why?
|
Prostate-Specific Antigen | 1 | 2015 | 358 | 0.110 |
Why?
|
Patient Care | 1 | 2014 | 102 | 0.110 |
Why?
|
Patient Satisfaction | 1 | 2016 | 461 | 0.110 |
Why?
|
Sex Factors | 1 | 2016 | 1062 | 0.110 |
Why?
|
Neoplasm Staging | 1 | 2017 | 1989 | 0.100 |
Why?
|
Clinical Competence | 2 | 2015 | 780 | 0.100 |
Why?
|
Problem-Based Learning | 1 | 2012 | 32 | 0.100 |
Why?
|
Gramicidin | 1 | 1992 | 24 | 0.100 |
Why?
|
Phosphatidylcholines | 1 | 1992 | 48 | 0.100 |
Why?
|
Conflict of Interest | 1 | 2011 | 68 | 0.100 |
Why?
|
Infant | 1 | 2018 | 3130 | 0.100 |
Why?
|
Lipid Bilayers | 1 | 1992 | 136 | 0.090 |
Why?
|
Smoking | 1 | 2014 | 620 | 0.090 |
Why?
|
Pulmonary Artery | 1 | 2012 | 318 | 0.090 |
Why?
|
Ion Channels | 1 | 1992 | 246 | 0.090 |
Why?
|
Fibrinolytic Agents | 2 | 2022 | 214 | 0.090 |
Why?
|
Follow-Up Studies | 1 | 2016 | 3649 | 0.080 |
Why?
|
Incidence | 1 | 2012 | 1591 | 0.080 |
Why?
|
Stroke Volume | 2 | 2021 | 461 | 0.080 |
Why?
|
Aged, 80 and over | 2 | 2017 | 6757 | 0.070 |
Why?
|
HIV Infections | 1 | 2016 | 830 | 0.070 |
Why?
|
Young Adult | 2 | 2017 | 6271 | 0.070 |
Why?
|
Models, Biological | 1 | 1992 | 1763 | 0.060 |
Why?
|
Drug Resistance, Microbial | 1 | 2024 | 75 | 0.060 |
Why?
|
Prostatic Neoplasms | 1 | 2015 | 1767 | 0.060 |
Why?
|
Doxycycline | 1 | 2022 | 28 | 0.050 |
Why?
|
Animals | 1 | 2021 | 27272 | 0.050 |
Why?
|
Contraindications, Procedure | 1 | 2021 | 7 | 0.050 |
Why?
|
Contraindications, Drug | 1 | 2021 | 4 | 0.050 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2023 | 89 | 0.050 |
Why?
|
Nephrologists | 1 | 2021 | 10 | 0.050 |
Why?
|
Prasugrel Hydrochloride | 1 | 2021 | 4 | 0.050 |
Why?
|
Urinalysis | 1 | 2021 | 31 | 0.050 |
Why?
|
Purinergic P2Y Receptor Antagonists | 1 | 2021 | 6 | 0.050 |
Why?
|
Blood Loss, Surgical | 1 | 2022 | 115 | 0.050 |
Why?
|
Troponin | 1 | 2021 | 24 | 0.050 |
Why?
|
Septal Occluder Device | 1 | 2021 | 44 | 0.050 |
Why?
|
Age Factors | 2 | 2015 | 1862 | 0.050 |
Why?
|
Hepacivirus | 1 | 2021 | 129 | 0.050 |
Why?
|
Percutaneous Coronary Intervention | 1 | 2021 | 62 | 0.050 |
Why?
|
Device Removal | 1 | 2021 | 167 | 0.040 |
Why?
|
Disease Outbreaks | 1 | 2000 | 154 | 0.040 |
Why?
|
Aftercare | 1 | 2020 | 87 | 0.040 |
Why?
|
Influenza Vaccines | 1 | 2000 | 148 | 0.040 |
Why?
|
Ischemic Attack, Transient | 1 | 2021 | 182 | 0.040 |
Why?
|
Global Health | 1 | 2000 | 186 | 0.040 |
Why?
|
Aminoglycosides | 1 | 2018 | 32 | 0.040 |
Why?
|
Heart Valve Prosthesis | 1 | 2019 | 97 | 0.040 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2018 | 40 | 0.040 |
Why?
|
Wounds and Injuries | 1 | 2021 | 257 | 0.040 |
Why?
|
Thyrotropin | 1 | 2019 | 286 | 0.040 |
Why?
|
Postpartum Period | 1 | 2019 | 144 | 0.040 |
Why?
|
Medical History Taking | 1 | 2018 | 81 | 0.040 |
Why?
|
Reference Values | 1 | 2019 | 661 | 0.040 |
Why?
|
alpha 1-Antitrypsin Deficiency | 1 | 2017 | 12 | 0.040 |
Why?
|
Forecasting | 1 | 2019 | 305 | 0.040 |
Why?
|
Spirometry | 1 | 2017 | 68 | 0.040 |
Why?
|
Drug Labeling | 1 | 2017 | 41 | 0.040 |
Why?
|
Antiviral Agents | 1 | 2000 | 474 | 0.040 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2019 | 178 | 0.040 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2016 | 73 | 0.030 |
Why?
|
Heart Diseases | 1 | 2018 | 298 | 0.030 |
Why?
|
False Positive Reactions | 1 | 2015 | 222 | 0.030 |
Why?
|
Disease Management | 1 | 2017 | 328 | 0.030 |
Why?
|
Glomerular Filtration Rate | 1 | 2015 | 275 | 0.030 |
Why?
|
Gastroenterology | 1 | 2015 | 144 | 0.030 |
Why?
|
Models, Structural | 1 | 1992 | 58 | 0.030 |
Why?
|
Vertebroplasty | 1 | 2012 | 8 | 0.030 |
Why?
|
Spinal Injuries | 1 | 2012 | 21 | 0.030 |
Why?
|
Mathematics | 1 | 1992 | 191 | 0.020 |
Why?
|
Prostate | 1 | 2015 | 393 | 0.020 |
Why?
|
Macromolecular Substances | 1 | 1992 | 177 | 0.020 |
Why?
|
Biopsy | 1 | 2015 | 1180 | 0.020 |
Why?
|
Drug Approval | 1 | 2012 | 66 | 0.020 |
Why?
|
Cohort Studies | 1 | 2017 | 2853 | 0.020 |
Why?
|
Testosterone | 1 | 2012 | 275 | 0.020 |
Why?
|
Adolescent | 1 | 2022 | 9201 | 0.020 |
Why?
|
Kinetics | 1 | 1992 | 1527 | 0.020 |
Why?
|
Retrospective Studies | 1 | 2023 | 8960 | 0.020 |
Why?
|
Stents | 1 | 2012 | 395 | 0.020 |
Why?
|
Prospective Studies | 1 | 2017 | 4255 | 0.020 |
Why?
|
Writing | 1 | 2008 | 29 | 0.020 |
Why?
|
Coronary Artery Disease | 1 | 2012 | 362 | 0.020 |
Why?
|
Surveys and Questionnaires | 1 | 2015 | 2607 | 0.020 |
Why?
|
Thromboembolism | 1 | 2000 | 120 | 0.010 |
Why?
|
Gastrointestinal Diseases | 1 | 2000 | 150 | 0.010 |
Why?
|